Publications by authors named "Rory Plant"
Article Synopsis
- Adalimumab is a monoclonal antibody designed to target TNF-alpha and is used to treat various autoimmune diseases, but there's limited evidence linking it to granulomatous interstitial nephritis (GIN).
- A 52-year-old man with psoriatic arthropathy experienced a decline in kidney function after starting adalimumab, leading to a renal biopsy that confirmed GIN.
- After stopping adalimumab, the patient's kidney function gradually improved over six months, highlighting the need for monitoring renal health in patients on anti-TNF therapies due to possible rare autoimmune reactions like GIN.
